| P2093 | author name string | Juan Wang | |
| | Yuanyuan Zhang | |
| | Kun Zhang | |
| | Qin Qin | |
| | Baosheng Li | |
| P2860 | cites work | The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 |
| | Cancer statistics, 2014 | Q27861018 |
| | Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes | Q30387489 |
| | Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging | Q31159102 |
| | Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers | Q33914586 |
| | Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study | Q34288344 |
| | Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group | Q34347886 |
| | Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer | Q35994474 |
| | Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound | Q36107597 |
| | Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging | Q36193014 |
| | Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging | Q37023284 |
| | N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. | Q37934301 |
| | The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement | Q38008614 |
| | Mediastinal lymph node staging: from noninvasive to surgical | Q38021757 |
| | Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging | Q38043166 |
| | Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? | Q43086231 |
| | CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group | Q44401801 |
| | Non-small cell lung cancer: dual-modality PET/CT in preoperative staging | Q44598378 |
| | The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax | Q46192851 |
| | Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma | Q46586863 |
| | Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results | Q46634592 |
| | STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients | Q46981366 |
| | Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging | Q47977328 |
| | Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. | Q51695133 |
| | Endosonographic mediastinal lymph node staging of lung cancer. | Q53063575 |
| | Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? | Q53098941 |
| | Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. | Q53153251 |
| | Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. | Q53267582 |
| | Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. | Q53426186 |
| | Radiological and "imaging" methods in TNM classification of non-small-cell lung cancer. | Q53460138 |
| | Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. | Q53566426 |
| | Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. | Q54131912 |
| | Contrast-enhanced MRI for the staging of bronchogenic carcinoma: Comparison with CT and histopathologic staging — Preliminary results | Q67802080 |
| | Preoperative evaluation of bronchogenic carcinoma: value of MR in T- and N-staging | Q68095467 |
| | Bronchogenic carcinoma staging: CT versus MR imaging. Assessment with surgery | Q68115166 |
| | A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma | Q69428548 |
| | Magnetic resonance imaging of mediastinal and hilar masses: comparison with CT | Q69869203 |
| | Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma | Q73046204 |
| | PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma | Q73049698 |
| | MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA | Q73175399 |
| | Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma | Q73504398 |
| | Imaging of mediastinal lymph nodes: CT, MR, and FDG PET | Q77331225 |
| | Pulmonary hilar lymph nodes in lung cancer: assessment with 3D-dynamic contrast-enhanced MR imaging | Q78819182 |
| | Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging | Q81830567 |
| | Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient | Q82717524 |
| | A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer | Q83517552 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 123-32 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Thoracic Cancer | Q26842004 |
| P1476 | title | Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis | |
| P478 | volume | 6 | |